Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P3LZ
|
||||
Former ID |
DIB020410
|
||||
Drug Name |
MRS1066
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C21H16O4
|
||||
InChI |
InChI=1S/C21H16O4/c1-2-23-21-16-10-11-24-18(16)13-19-20(21)17(22)12-15(25-19)9-8-14-6-4-3-5-7-14/h3-13H,2H2,1H3/b9-8+
|
||||
InChIKey |
TZRUAYHMQMKKLT-CMDGGOBGSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2b receptor | Target Info | Antagonist | [2] | |
Adenosine A1 receptor | Target Info | Antagonist | [2] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Calcium signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Vascular smooth muscle contraction | |||||
Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
cAMP signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Morphine addiction | |||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
TCR Signaling PathwayNetPath_11:TCR Signaling Pathway | |||||
RANKL Signaling Pathway | |||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Pathway Interaction Database | C-MYB transcription factor network | ||||
PathWhiz Pathway | Intracellular Signalling Through Adenosine Receptor A2b and Adenosine | ||||
Reactome | Adenosine P1 receptors | ||||
G alpha (s) signalling events | |||||
Surfactant metabolismR-HSA-417973:Adenosine P1 receptors | |||||
G alpha (i) signalling events | |||||
WikiPathways | Nucleotide GPCRs | ||||
GPCRs, Class A Rhodopsin-like | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP80:Nucleotide GPCRs | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 396). | ||||
REF 2 | J Med Chem. 1996 Jun 7;39(12):2293-301.Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.